论文部分内容阅读
将体重200—280g的Wistar雄性健康大鼠按体重随机分为糖尿病治疗组、对照组、正常对照组三组,按本室方法用链脲估菌素(STZ,美国Sigma产品)对糖尿病治疗组、对照组大鼠腹腔注射,体重30mg/kg,每日
Wistar male healthy rats weighing 200-280g were randomly divided into three groups: diabetes treatment group, control group, and normal control group according to body weight. According to the method of this room, streptozotocin (STZ, US Sigma product) to diabetes treatment group Rats in the control group were injected intraperitoneally with a body weight of 30 mg/kg daily.